PovorcitinibA Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
PHASE3
Sponsor:
Incyte Corporation
Location:
St. John's, Scottsdale AZ, Arkansas AR, Fayetteville ARshow 40 more